ADVANCE study provides evidence for shift to dolutegravir-containing ART in SA
The South African study shows that dolutegravir-containing regimens perform as well as the current efavirenz-containing one used for first-line antiretroviral treatment (ART) in South Africa and most of Africa.
Jul 24, 2019
0
1
